{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Hazel Reese didn't realize she was suicidal until the day she was filling out the intake form at her first appointment at Chicago's Diamond Headache Clinic in 1982. That was when she read the question asking if she had ever tried to take her own life.", "headline": {"main": "A Lifetime of Pain, and She Still Will Not Complain", "kicker": "Migraine"}, "abstract": "The author speaks with Hazel Reese, a 63-year-old woman who suffered hardship on top of headaches, and survived.", "print_page": null, "word_count": 2090, "_id": "4fd36a838eb7c8105d8be3ec", "snippet": "The author speaks with Hazel Reese, a 63-year-old woman who suffered hardship on top of headaches, and survived.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://migraine.blogs.nytimes.com/2008/02/28/a-lifetime-of-pain-and-she-still-will-not-complain/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Paula", "lastname": "KAMEN"}], "original": "By PAULA KAMEN"}, "document_type": "blogpost", "pub_date": "2008-02-28T18:11:54Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Widely used anemia drugs sold by Amgen and Johnson & Johnson raise the risk of death among cancer patients by about 10 percent, a newly published analysis says.", "headline": {"main": "Study Finds Death Risk From Anemia Drugs", "print_headline": "Study Finds Increased Death Risk From Anemia Drugs"}, "abstract": null, "print_page": "2", "word_count": "744", "_id": "547e77837988107cec11b715", "snippet": "Widely used anemia drugs sold by Amgen and Johnson & Johnson raise the risk of death among cancer patients by about 10 percent, a newly published analysis says.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/02/27/business/27anemia.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Anemia", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Amgen Inc", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Johnson & Johnson Inc", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "American Medical Assn", "is_major": "N", "rank": "7", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2008-02-27T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Widely used anemia drugs raise the risk of death among cancer patients by about 10 percent, an analysis shows.", "headline": {"main": "Death Risk Found From Anemia Drugs"}, "abstract": null, "print_page": null, "word_count": "739", "_id": "547e75007988107cec11b6d4", "snippet": "Widely used anemia drugs raise the risk of death among cancer patients by about 10 percent, an analysis shows.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/02/26/business/26cnd-anemia.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Johnson & Johnson Inc", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Amgen Inc", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Anemia", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2008-02-26T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial", "lead_paragraph": "Ralph Nader argues that his voice is crucial to combat corporate greed, Pentagon waste and unworkable health care plans. (Remind us. Which candidate is for any of these things?)", "headline": {"main": "Ralph Nader: Going, Going, Not Gone", "kicker": "Editorial Notebook", "print_headline": "Ralph Nader: Going, Going, Not Gone", "content_kicker": "Editorial Notebook"}, "abstract": null, "print_page": "18", "word_count": "371", "_id": "547e6e9c7988107cec11b633", "snippet": "Ralph Nader argues that his voice is crucial to combat corporate greed, Pentagon waste and unworkable health care plans. (Remind us. Which candidate is for any of these things?)", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/02/26/opinion/26tue4.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Nader, Ralph", "is_major": "N", "rank": "1", "name": "persons"}, {"value": "Presidential Election of 2008", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Democratic Party", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "LaRouche, Lyndon", "is_major": "N", "rank": "4", "name": "persons"}, {"value": "Editorials", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Elections", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Eleanor", "lastname": "RANDOLPH"}], "original": "By ELEANOR RANDOLPH"}, "document_type": "article", "pub_date": "2008-02-26T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONALA3-10 North Korea Welcomes New York's Orchestra", "headline": {"main": "News Summary"}, "abstract": null, "print_page": "2", "word_count": 864, "_id": "4fd2b2b18eb7c8105d8a3e18", "snippet": "INTERNATIONALA3-10     North Korea Welcomes New York's Orchestra", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C03E5DD1230F935A15751C0A96E9C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2008-02-26T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "SundayBusiness", "lead_paragraph": "A new drug aimed at treating schizophrenia turns its focus away from dopamine and instead on the effects of glutamate, another powerful neurotransmitter.", "headline": {"main": "Daring to Think Differently About Schizophrenia", "print_headline": "Daring to Think Differently About Schizophrenia"}, "abstract": null, "print_page": "1", "word_count": "2666", "_id": "547e55b57988107cec11b3d8", "snippet": "A new drug aimed at treating schizophrenia turns its focus away from dopamine and instead on the effects of glutamate, another powerful neurotransmitter.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/02/24/business/24drug.html", "multimedia": [{"subtype": "wide", "url": "images/2008/02/24/business/24DRUGa.190.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2008/02/24/business/24DRUGa.190.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2008/02/24/business/24cover.xlarge1.jpg", "height": 350, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2008/02/24/business/24cover.xlarge1.jpg", "xlargeheight": "350"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2008/02/24/business/24cover.751.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/02/24/business/24cover.751.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Schizophrenia", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Lilly, Eli, & Co", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "National Institute of Mental Health", "is_major": "N", "rank": "5", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Alex", "lastname": "BERENSON"}], "original": "By ALEX BERENSON"}, "document_type": "article", "pub_date": "2008-02-24T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 6, "offset": 0, "time": 51}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}